Public source overview

Updates

Public Source Overview

Use this page to read current court and FDA source summaries inside the site and follow the connected reading path from one place.

  • Court page, JPML report, and FDA update summaries
  • Read the site summary first before deciding what to open next
  • Official court, EMA, and FDA sources re-checked on April 3, 2026.

Latest public references

Read the newest source summaries inside the site first

These cards keep the reading path inside the site so visitors can review the key points in one place.

Official court source

2026-01-26

MDL 3163 court page

The Eastern District of Pennsylvania keeps the official MDL 3163 page, conference access, orders, and related public court materials in one place.

Read MDL 3163 summary

Official docket report

2026-04-01

JPML monthly pending MDL report

The April 1, 2026 JPML pending report lists MDL 3163 with 73 pending actions and keeps the GLP-1 / NAION litigation inside the national pending-MDL…

Read JPML summary

Official FDA source

2026-03-03

FDA warning letters on compounded GLP-1 marketing

FDA announced 30 warning letters addressing false or misleading telehealth marketing of compounded GLP-1 products and clarified that compounded drugs are not FDA-approved.

Read FDA summary

Keep reading

Updates

You can return to the updates hub or Resource Center when you want broader context.

Use the updates hub for nearby topic pages, or return to Resource Center for guides and curated reading.